Equities

Progyny Inc

PGNY:NSQ

Progyny Inc

Actions
  • Price (USD)32.16
  • Today's Change-0.90 / -2.72%
  • Shares traded215.00
  • 1 Year change-7.72%
  • Beta1.5056
Data delayed at least 15 minutes, as of May 08 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.4 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.

  • Revenue in USD (TTM)1.09bn
  • Net income in USD62.04m
  • Incorporated2008
  • Employees563.00
  • Location
    Progyny Inc1359 BroadwayNEW YORK 10018United StatesUSA
  • Phone+1 (212) 888-3124
  • Fax+1 (302) 636-5454
  • Websitehttps://www.progyny.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
NeoGenomics, Inc.610.66m-84.23m1.93bn2.10k--2.09--3.16-0.6698-0.66984.867.250.364615.884.69290,791.90-5.03-3.57-5.29-3.8041.8041.09-13.79-9.367.22--0.3685--16.0716.4139.02--14.98--
Brightspring Health Services Inc8.83bn-154.60m1.95bn35.00k--2.2942.810.2207-0.9204-0.920457.534.96------252,176.40--------16.2417.75-1.78-0.62890.84420.97830.8473--14.3228.33-186.80--17.24--
Teladoc Health Inc2.62bn-233.03m2.07bn5.60k--0.902515.660.7899-1.40-1.4015.8013.520.60719.5812.18467,732.50-5.40-33.54-5.93-34.6370.8168.59-8.90-171.393.74--0.4021--8.1344.1698.39--79.43--
Agilon Health Inc4.32bn-195.05m2.13bn1.12k--3.19--0.4943-0.4885-0.657610.511.632.51--5.993,864,246.00-11.36---20.26--7.13---4.52-----13,643.820.0551--80.74---112.01------
Astrana Health Inc1.39bn60.72m2.13bn1.80k29.432.9028.231.541.291.2929.5613.111.46--11.07770,367.806.097.096.739.3915.5018.304.176.36----0.405510.5421.1921.6834.4241.1689.42--
Privia Health Group Inc1.66bn23.08m2.24bn1.10k101.833.9781.201.350.18520.185213.304.751.85--6.901,504,299.002.35--3.91--9.749.151.27-2.56----0.00--22.1920.31368.83---12.48--
Lifestance Health Group Inc1.06bn-186.26m2.67bn9.33k--1.85--2.53-0.5059-0.50592.873.770.4929--9.33113,208.00-8.70---9.54-------17.64-----5.690.1654--22.82--13.59------
Quidelortho Corp3.00bn-10.10m2.85bn7.10k--0.56876.380.9522-0.1542-0.154244.8175.050.34422.737.03422,225.30-0.11611.34-0.129712.9149.8562.71-0.336920.930.87881.710.32540.00-8.2141.83-101.84--45.87--
Irhythm Technologies Inc513.17m-129.96m3.07bn2.00k--34.01--5.99-4.22-4.2216.712.900.770910.857.37256,587.00-19.52-21.92-22.55-26.7766.9669.39-25.33-25.756.95-18.440.877--19.9027.32-6.24--50.82--
Amedisys Inc2.25bn-20.59m3.07bn19.00k--2.831,011.261.37-0.6446-0.644668.7333.301.12--6.89118,495.10-1.057.82-1.3810.3944.3943.63-0.94395.89--11.620.25610.000.5936.11-108.22--14.16--
Progyny Inc1.09bn62.04m3.09bn563.0052.175.6048.062.840.61640.616410.815.741.68--4.521,933,567.009.5511.5013.0016.0221.9421.485.706.64----0.000.0038.3459.52104.35--44.47--
Evolent Health Inc1.96bn-142.26m3.17bn4.70k--2.91--1.61-1.28-1.2817.6510.940.8733--5.60417,850.20-5.03-9.60-6.67-12.5923.4524.50-5.76-13.66--0.26850.3239--45.2625.65-660.71---6.18--
Surgery Partners Inc2.79bn600.00k3.45bn10.50k8,937.501.7612.491.240.0030.00322.1415.480.410424.895.90266,142.802.331.173.201.6333.7326.335.673.031.562.470.4606--8.039.1478.21--17.41--
PACS Group Inc-100.00bn-100.00bn3.70bn32.43k------------------------------------------------28.47---25.00------
Radnet Inc1.62bn3.04m3.74bn7.87k56,255.555.4623.572.310.00090.000925.329.280.631--8.64205,364.601.181.241.561.6621.6721.561.881.86--1.470.50510.0013.0510.64-71.42-37.6319.60--
Select Medical Holdings Corp6.79bn259.99m4.27bn38.40k15.743.087.880.62912.092.0954.6210.650.8726--6.37176,767.904.264.195.265.4614.4413.984.895.11--3.780.697815.305.225.5753.0311.986.50--
Data as of May 08 2024. Currency figures normalised to Progyny Inc's reporting currency: US Dollar USD

Institutional shareholders

39.90%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 31 Dec 20239.83m10.19%
The Vanguard Group, Inc.as of 31 Dec 20238.04m8.33%
ClearBridge Investments LLCas of 31 Dec 20233.49m3.62%
Weatherbie Capital LLCas of 31 Dec 20232.93m3.03%
JPMorgan Investment Management, Inc.as of 31 Dec 20232.80m2.90%
SSgA Funds Management, Inc.as of 31 Dec 20232.79m2.89%
Jennison Associates LLCas of 31 Mar 20242.60m2.69%
Thrivent Asset Management LLCas of 31 Dec 20232.20m2.28%
Riverbridge Partners LLCas of 31 Mar 20242.00m2.07%
Geode Capital Management LLCas of 31 Dec 20231.83m1.90%
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.